Brief: Cipla Says U.S. Unit To Initiate Recall Of Lanreotide Injection
09/03/2026 20:33
March 9 (Reuters) - Cipla Ltd CIPL.NS: U.S. UNIT TO INITIATE RECALL OF LANREOTIDE INJECTION, TEMPORARY SUPPLY SHORTAGE EXPECTED Source text: ID:nNSE7dfw5l Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated